Publication | Closed Access

Impact of early inflammatory cytokine elevation after commencement of PD-1 inhibitors to predict efficacy in patients with non-small cell lung cancer

Cancer ImmunosurveillanceInflammatory Lung DiseaseLung InflammationMedicineImmunologyPd-1 InhibitorsBronchial NeoplasmImmune Checkpoint InhibitorCancer TreatmentLung CancerOncologyRadiation OncologyTumor Microenvironment